VIVO Cannabis Inc.: VIVO Cannabis Announces Publication of Medical Cannabis Clinical Research Study in Psychiatric Research: Anxiety & Depression Outcomes in Medical Cannabis Patients

Toronto, Ontario--(Newsfile Corp. - June 3, 2022) - VIVO Cannabis Inc. (TSX: VIVO) (OTCQX: VVCIF) ("VIVO" or the "Company"), a leading provider of medical cannabis products and patient services, and holder

Related Keywords

Germany ,Australia ,Canada ,Toronto ,Ontario ,Canadian ,Carole Chan ,Michael Bumby ,Instagram ,Linkedin ,Twitter ,Canna Farms Limited ,Newsfile Corp ,Abcann Medicinals Inc ,Cannabis Inc ,Harvest Medicine Inc ,Facebook ,Psychiatry Research ,Health Canada ,Cannabis Act ,Medicinals Inc ,Medicine Inc ,Harvest Medicine ,Canna Farms ,Beacon Medical ,Chief Financial ,Forward Looking Information ,Vivo ,Cannabis ,Nnounces ,Publication ,Medical ,Linical ,Research ,Study ,Psychiatric ,Anxiety ,Depression ,Outcomes ,Patients ,